scholarly journals Why there are and will be less deaths in India due to COVID-19: an insight

2020 ◽  
Vol 7 (8) ◽  
pp. 3301
Author(s):  
Chincholikar Sanjeev Vasantrao
Keyword(s):  
Cardiovascular Disease ◽  
Respiratory Disease ◽  
Kidney Diseases ◽  
Heart Diseases ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Special Treatment ◽  
Medical Problems ◽  
Health Organization

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. It has been declared a pandemic by the World Health Organization which exhibited human-to-human transmissibility and spread rapidly across countries. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Climate, with temperature, humidity, Bacillus Calmette–Guérin (BCG) vaccination, immune status of persons, elderly people, uncontrolled co morbid conditions like heart diseases, diabetes mellitus, hypertension, kidney diseases seems to play an important role in spread and severity of corona virus infection. As reported from MOHFW website, the COVID-19 deaths are more in above 60 years of age with comorbidities cardiovascular disease, diabetes, chronic respiratory disease, and cancer.

Global Pandemic of a Century: A Review on the Coronavirus (COVID-19)

2020 ◽  
Vol 7 (4) ◽  
pp. 17-26
Author(s):  
Jitendra Mehta ◽  
Keyword(s):  
Respiratory Disease ◽  
Rna Virus ◽  
Severe Disease ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Director General ◽  
Global Pandemic ◽  
The World ◽  
Health Organization

Coronavirus disease 2019 (COVID-19) emerged in December 2019 in Wuhan, the capital of Hubei province, China. While the outbreak in China is almost over, this highly contagious disease is currently spreading across the world with a daily increase in the number of affected countries, confirmed cases, and infection-related deaths. In January, the World Health Organization (WHO) declared that the outbreak of COVID-19 constituted a Public Health Emergency of International Concern (PHEIC). Based on the high levels of global spread and the severity of COVID-19, on 11 March 2020, the Director-General of the WHO declared the COVID-19 outbreak a pandemic. COVID-19 is an acute respiratory disease caused by a newly emerged zoonotic coronavirus. A positive-sense enveloped single-stranded RNA virus, named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been isolated from a patient with pneumonia and connected to the cluster of acute respiratory illness cases from Wuhan. The virus is transmitted from human to human via droplets coughed or exhaled by infected persons and by touching droplet-contaminated surfaces or objects and then touching the eyes, nose, or mouth. Population groups that have been more frequently reported as having severe disease and a higher mortality rate include people aged over 60 years, males, people with underlying conditions such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease, and cancer. Current estimates suggest a median incubation period of five to six days for COVID-19, with a range of one to 14 days. Disease-specific pharmaceuticals and vaccines are still under research and development. The therapeutic use of convalescent plasma donated by patients recovered from COVID-19 might play a role in the efforts to find a possible treatment for COVID-19. Keywords: Coronavirus, COVID-19, WHO, SARS-Cov-2, Zoonotic.

scholarly journals Coronavirus Pandemic: Emergence, Transmission, Preventive Measures and Management

1970 ◽  
Vol 8 (2) ◽  
pp. 45-49
Author(s):  
Mahaveer Prasad Khinchi ◽  
Mohd. Shahid Khan ◽  
Simranjeet Singh Saluja
Keyword(s):  
Preventive Measures ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Medical Problems ◽  
Public Places ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Spread Of Infection ◽  
Meat Market

Coronavirus is found in animals and, rarely, can be transmitted from animals to humans and then spread person to person. An occurrence of the coronavirus infection (COVID-19) in China is causing global concern. It came from a seafood and meat market in Wuhan, China, in December 2019. It has since spread to many countries around the world including India. World Health Organization (WHO) declared novel coronavirus eruption a “pandemic” on March 11th, 2020. Patients infected with the COVID-19 virus will experience mild to moderate respiratory illness. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Prevent spread of infection by washing hands or using an alcohol based rub frequently and not touching face. This virus transmits primarily through droplets of saliva or discharge from the nose when adiseased person coughs or sneezes, so it’s important to cover face by mask and coughing into a flexed elbow at public places. Currently there are no specific vaccines or treatments for COVID-19. In this review, we summarize recent information about the emergence, tansmission, preventive measures and therapeutic options available now.    

scholarly journals Get vaccinated when it is your turn and follow the local guidelines

2021 ◽  
Vol 5 (3) ◽  
Author(s):  
I Wayan Suryasa ◽  
María Rodríguez-Gámez ◽  
Tihnov Koldoris
Keyword(s):  
Infectious Disease ◽  
Cardiovascular Disease ◽  
Older People ◽  
Respiratory Disease ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Special Treatment ◽  
Infected Person ◽  
Medical Conditions ◽  
Respiratory Droplets

The nurse has an important role caring for the patient infected with the coronavirus disease (COVID- 19). It is an infectious disease caused by the SARS-CoV-2 virus. The virus can spread from the mouth or nose of an infected person in small liquid particles when they cough, sneeze, speak, sing, or breathe. These particles range from larger respiratory droplets to smaller aerosols. It is important to practice respiratory etiquette, for example coughing into a flexed elbow, and to stay home and self-isolate until you recover if you feel unwell. Most people infected with the virus will experience mild to moderate respiratory illness and will recover without requiring special treatment. Older people and people with underlying medical conditions such as cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illnesses. The goal of the research is to propose the best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads. Protect yourself and others from infection by staying at least 1 meter away from others, wearing a well-fitting mask, and washing your hands or using an alcohol-based rub frequently.

THE EFFECTS OF CORONAVIRUS (COVID-19) IN ENGLISH LANGUAGE AND LITERATURE CLASSROOM OF GUJARAT STATE.

2020 ◽  
pp. 74-79
Author(s):  
Om Joshi
Keyword(s):  
English Language ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Language Teachers ◽  
Special Treatment ◽  
Family Welfare ◽  
Medical Problems ◽  
Gujarat State ◽  
Literature Classroom ◽  
Language And Literature

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.Coronavirus disease (COVID-19) has taken so many innocent lives, as it spread most of the corner of the world and Gujarat, India oneof them. At present March 2020, most of the institutes and universities do ready to complete the course and repeats the topic in the classroom. As we know that, because of Coronavirus disease (COVID19)University Grants Commission, Health and Family Welfare Department and Education Department, Govt. of Gujaratinstructed to all the institutes and universities to remain closed till further instructions.In this period, researcher wishes to knowthe situation of the English language and literature classroom of Gujarat state. Researcher will refer the online circularsof different institutes and universities of Gujaratstate andwill do the telephonic interviews of English language teachers, based on the data, researcher will discuss the effects of Coronavirus disease (COVID-19) in English language and literature classroom.

scholarly journals Dataset on the COVID-19 Pandemic Situation in Tunisia with application to SIR Model

2020 ◽  
Author(s):  
Abir Lassoued ◽  
Afef Ben Saad ◽  
Hela Lassoued ◽  
Raouf Ketata ◽  
Olfa Boubaker
Keyword(s):  
Respiratory Disease ◽  
Severe Disease ◽  
Developed Countries ◽  
Sir Model ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Life Saving ◽  
Geographical Regions ◽  
The World ◽  
Health Organization

AbstractApril 9, 2020 marks 100 days since first cases of the Coronavirus Disease 2019 in China. In this crucial day with 1 436 198 confirmed infected cases in the world (New confirmed infected cases 82 837) and 85 521 deaths (6286 New daily deaths), the Global Level of the Covid-19 pandemic is evaluated at very high according to the World Health Organization (WHO) situation report. For most people, COVID-19 infection will cause mild illness (fever and at least one sign/symptom of respiratory disease), however for more than 3.4% of people, it can be fatal. Older people and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are at risk for severe disease and mortality. The incubation period of the virus is estimated to be between 2 and 14 days but longer incubation are reported. Furthermore, Data published by world authorities shows that statistics are different for different geographical regions and depends on many social and environmental factors. The sad reality of the COVID-19 is that there are currently no medications or vaccines proven to be effective for the treatment or prevention of the disease. The pandemic spread is consequenctly followed by a worldwide panic. Facing this dramatic uncertain situation, implementing a country wide strategy for social distancing and a general logistic policy for critical and life-saving supplies is an urgency for governomental and sanitaire authorities. Several mathematical models have been proposed for developed countries to predict the epidemic spread. However these models can’t be adapted to developing countries due to the major differences in geographic, societal, economic and political adopted strategies. Here, we propose the application of the well known SIR model to the case study of Tunisia where Data are collected from three official databases showing differences in reporting methods. The proposed data could be useful to predict the spread of COVID-2019 and design a more reliable model that can estimate the finale size of the spread and help in monitoring infection control.Specifications Table

scholarly journals A REVIEW TO SUMMARIZE THE AVAILABLE EVIDENCES ON TURMERIC'S (CURCUMA LONGA) MEDICINAL PROPERTIES TO UNDERSTAND THE SCOPE OF ITS EFFICACY IN THE TREATMENT AND PREVENTION OF COVID19 DISEASES.

2020 ◽  
pp. 7-14
Author(s):  
Vd. Anagha Kothadia ◽  
Geeta D. Parulkar
Keyword(s):  
Curcuma Longa ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Special Treatment ◽  
Intermediate Hosts ◽  
Medical Problems ◽  
Evidence Based Treatment ◽  
Routes Of Administration ◽  
Treatment And Prevention ◽  
Medicinal Properties

The massive outbreak of coronavirus disease (COVID-19) across the world, has affected more than 200 countries and territories which was originated in bats and transmitted to humans through unknown intermediate hosts in the Wuhan seafood market, China, in December of 2019. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. There is no system of medicine has any evidence-based treatment for COVID-19 yet and vaccine is recommended. WHO is helping to accelerate drug research. In India, Ministry of Ayush has issued guidelines which contain preventive and remedial information and advisories for the management of COVID19 symptoms. This review has assembled evidences of Turmeric/Curcuma longa which is one of the ingredient of the ayurvedic preventive majors issued by Ministry of Ayush and revealed various routes of administration of Turmeric /Curcuma longa asserted in Ayurvedic Texts as a remedy and additional preventive majors for COVID 19 symptoms.

Study the Anatomy and Physiology of Body's Urinary System and Fibromyalgia Syndrome (FMS) for the Design an Intelligent Alarm System for Monitoring of FMS

2019 ◽  
Vol 1 (1) ◽  
pp. 72-81
Author(s):  
Hamidreza Shirzadfar ◽  
Narsis Gordoghli
Keyword(s):  
Chronic Pain ◽  
International Association ◽  
Continuous Process ◽  
Well Being ◽  
Chronic Illnesses ◽  
World Health ◽  
Definitive Treatment ◽  
Psychological Consequences ◽  
Medical Problems ◽  
Health Organization

In recent years, chronic medical problems have become increasingly prevalent. Chronic ‎illnesses challenge the view of life as a regular and continuous process, a challenge that has ‎important psychological consequences. The long duration of people suffering from these ‎diseases, the long process of treatment and the fact that there is no proper and definitive ‎treatment for most of these diseases and their associated complications have made chronic ‎diseases a detrimental factor in public health. According to the World Health Organization ‎‎(2006), the prevalence of chronic and non-communicable diseases is increasing in all countries, ‎especially developing countries, so that the major challenge for the health system in the present ‎century, is not living people, but better adapted to chronic illnesses and maintaining their ‎mental and social health and well-being Ed's life-threatening chronic physical illness.‎ Chronic pain is a pain that lasts longer than usual, and according to the criteria of the ‎International Association of Pain, this time is defined as at least 3 months to 6 months. Chronic ‎pain is such that not only faced the sick person whit the pressure of the pain but also with many ‎other pressure that affect different parts of her life. Fibromyalgia is one of the most rheumatologic disorders and one of the most resistant chronic ‎pain syndromes. Fibromyalgia is one of the most common musculoskeletal disorders in adults ‎and chronic pain is one of the most common complaints in this group of patients.

A short review on important drugs under clinical trial against Covid-19

2020 ◽  
Vol 21 ◽  
Author(s):  
Namita Misra
Keyword(s):  
Respiratory Illness ◽  
Short Review ◽  
World Health ◽  
Upper Respiratory Tract ◽  
Suspected Infection ◽  
Medicinal Treatment ◽  
Travel Restrictions ◽  
Personal Level ◽  
Health Organization ◽  
Tract Infections

: Corona virus spreads from one to other person, either by touching the hands or by touching the surface contaminated with this virus, and then touching the nose or mouth. Covid-19 infected human symptoms are like any pneumonia symptoms, dry cough and high fever. Upper respiratory tract infections symptoms and sore throat are rare. First notified in china dated 12th December 2019 as a respiratory illness. In addition to travel restrictions and quarantine measures everyone should follow the World Health Organization advice guidelines on the management of humans infected with known or suspected infection with SARS-CoV-2 virus at the personal level. The development of vaccine or medicines for the same are under progress and this short review will summarize the most potential candidates such as Remdesivir, Lopinavir and Ritonavir, Chloroquine, Hydroxychloroquine, Hydroxychloroquine with Azithromycin, Favipiravir, Umifenovir, and Ribavirin for its medicinal treatment.

scholarly journals An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Anupama M. Gudadappanavar ◽  
Jyoti Benni
Keyword(s):  
Antiviral Drug ◽  
Drug Repurposing ◽  
Respiratory Illness ◽  
World Health ◽  
Recombinant Vaccines ◽  
Subunit Vaccines ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Full Length Genome

AbstractA novel coronavirus infection coronavirus disease 2019 (COVID-19) emerged from Wuhan, Hubei Province of China, in December 2019 caused by SARS-CoV-2 is believed to be originated from bats in the local wet markets. Later, animal to human and human-to-human transmission of the virus began and resulting in widespread respiratory illness worldwide to around more than 180 countries. The World Health Organization declared this disease as a pandemic in March 2020. There is no clinically approved antiviral drug or vaccine available to be used against COVID-19. Nevertheless, few broad-spectrum antiviral drugs have been studied against COVID-19 in clinical trials with clinical recovery. In the current review, we summarize the morphology and pathogenesis of COVID-19 infection. A strong rational groundwork was made keeping the focus on current development of therapeutic agents and vaccines for SARS-CoV-2. Among the proposed therapeutic regimen, hydroxychloroquine, chloroquine, remdisevir, azithromycin, toclizumab and cromostat mesylate have shown promising results, and limited benefit was seen with lopinavir–ritonavir treatment in hospitalized adult patients with severe COVID-19. Early development of SARS-CoV-2 vaccine started based on the full-length genome analysis of severe acute respiratory syndrome coronavirus. Several subunit vaccines, peptides, nucleic acids, plant-derived, recombinant vaccines are under pipeline. This article concludes and highlights ongoing advances in drug repurposing, therapeutics and vaccines to counter COVID-19, which collectively could enable efforts to halt the pandemic virus infection.

Sign in / Sign up

Export Citation Format

Share Document